Pharmafile Logo
Pharmafocus logo
Advanced Search

Business Services

Pharmaceutical Business Services – News, analysis and company profiles

Showing 15 posts of 2453 posts found.

First Patient Dosed in Fifth Cohort of AVA6000 Phase Ia Dose Escalation Study

April 5, 2023 Business Services

Avacta Group plc (AIM: AVCT), a life sciences company developing innovative, targeted oncology drugs and powerful diagnostics, announces that the …
News
Press release

BenevolentAI announces top-line Phase IIa results for its topical pan-Trk inhibitor BEN-2293 (1%) in mild-to-moderate atopic dermatitis

April 5, 2023 Business Services

London, UK, 5 April 2023: BenevolentAI (“BenevolentAI” or the “Company”) (Euronext Amsterdam: BAI) announces top-line results from its Phase IIa, …
News
Press release

Phlo acquires Truepill UK in landmark digital pharmacy consolidation

April 4, 2023 Business Services

Glasgow, UK. Phlo Technologies UK digital pharmacy leaders, have today announced their acquisition of the UK arm of US-based healthcare …
News
Press release

Mosaic Therapeutics closes $28m series A funding and appoints Brian Gladsden as CEO

April 4, 2023 Business Services

Cambridge, UK, 04 April 2023 – Mosaic Therapeutics, Ltd, (‘Mosaic’, or ‘the Company’) an oncology therapeutics company dedicated to resolving …
News
Press release

Recipharm bolsters senior leadership team with appointment of Joaquim Mascaro as Chief Financial Officer

April 4, 2023 Business Services

Global contract development and manufacturing organisation (CDMO) Recipharm, has announced the appointment of Joaquim Mascaro as Chief Financial Officer.
Appointment
optibrium_appointment

Optibrium Appoints Computational Modelling Expert, Dr Hamed Tabatabaei Ghomi as Head of Research

April 4, 2023 Business Services

Appointment will lead research strategy to apply the latest scientific innovations to Optibrium’s computational and AI drug discovery technologies Hamed …
Appointment

Landmark data published on successful NTCD-M3 gut colonisation after fidaxomicin administration

April 4, 2023 Business Services

Brighton, United Kingdom – 4 April 2023 – Destiny Pharma (AIM: DEST), a clinical stage innovative biotechnology company focused on …
News
Press release

PHARMANOVIA RECEIVES SBTi APPROVAL FOR NET ZERO EMISSION TARGETS

April 4, 2023 Business Services

Basildon, UK, 3 April 2023 Pharmanovia, a global pharmaceutical company that revitalises, extends and expands the lifecycle of already established …
News
Press release
steve_jones_chief_financial_officer_for_ingenza

Ingenza appoints Steve Jones as its new Chief Financial Officer

April 4, 2023 Business Services Ingenza

  Ingenza appoints Steve Jones as its new Chief Financial Officer  
Appointment

Orbit Discovery and Evergreen Discovery collaborate to discover peptides for targeting radiopharmaceuticals

April 4, 2023 Business Services

New Jersey, USA, and Oxford, UK, 3rd April 2023: Evergreen Discovery (Evergreen), a leading radiopharmaceutical drug development company with a …
News
Press release

CrestOptics launches CICERO system to provide all-in-one solution for widefield and spinning disk confocal microscopy

April 3, 2023 Business Services

Rome, IT, 03 April, 2023: CrestOptics S.p.A., a manufacturer of high-end microscopy solutions and advanced systems for fluorescence microscopy and …
News
Press release

Sequana Medical announces submission of Investigational New Drug (IND) application for DSR® 2.0 for treatment of congestive heart failure

April 3, 2023 Business Services

Ghent, Belgium – 03 April 2023 – Sequana Medical NV (Euronext Brussels: SEQUA) (the “Company” or “Sequana
News
Press release

Novo Nordisk Foundation to support crucial education of health professionals in India and East Africa with up to DKK 1bn (USD 140m)

April 3, 2023 Business Services

Lack of access to qualified health personnel combined with an alarming prevalence of noncommunicable diseases (NCDs) such as cardiometabolic diseases …
News
Press release

Redx Confirms Proposed Business Combination with Jounce has Formally Lapsed

April 3, 2023 Business Services

Alderley Park, UK, 3 April 2023 Redx (AIM:REDX), the clinical-stage biotechnology company focused on discovering and developing novel, small molecule, …
News
Press release

Almirall: The New England Journal of Medicine (NEJM) and the British Journal of Dermatology (BJD) publish Ph3 data evaluating lebrikizumab efficacy and safety in moderate-to-severe atopic dermatitis

March 31, 2023 Business Services Almirall, Dermatology, dermatology, lebrikizumab

BARCELONA, Spain. March 31, 2023 – Almirall, S.A. (ALM), a global biopharmaceutical company focused on medical dermatology, announced today the …
News
Press release
The Gateway to Local Adoption Series

Latest content

STADA and Bio-Thera’s Gotenfia receives positive CHMP opinion for autoimmune diseases

December 18, 2025

Norgine enters exclusive licensing agreement with Vir Biotechnology

December 18, 2025

Incyclix appoints Kimberly Blackwell to Board of Directors

December 17, 2025

Hansa Biopharma appoints Max Sakajja as Vice President, General Manager Europe and International

December 17, 2025

GSK’s Exdensur receives MHRA approval for asthma and rhinosinusitis

December 16, 2025